We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical will be attending the 19th BIO KOREA International Convention, taking place from May 8-10, 2024, at COEX in Seoul.
BIO KOREA has been a leading platform for fostering growth in the global bio-health industry since 2006. As part of this event, we'll be participating in all major sections of this global indsutry event. Don't miss this opportunity to exchange insights on the latest bio-health trends, technology, and international expansion opportunities with industry experts, professionals, and CEOs.
Join us at BIO KOREA 2024 by booking a meeting with Polina Nabieva, OCT's Business Development Manager, pnabieva@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.